News

September 29, 2014September 29, 2014

FDA Grants Priority Review to Nivolumab For Melanoma Treatment

Melanoma, News

PD-1 inhibitor nivolumab (Opdivo) has been granted a priority review designation by the American Food and Drug Association (FDA), as a treatment for pretreated patients with advanced melanoma. This decision ... Read more

September 26, 2014September 26, 2014

Deployed Military Have Higher Risk of Developing Skin Cancer

News

Soldiers who are deployed into locations with tropical and sunny climates are returning to the United States with a higher risk of developing skin cancer, as concluded by a retrospective ... Read more

September 25, 2014September 25, 2014

Results On New Melanoma Drug PV-10 To Be Presented At The European Society for Medical Oncology Congress

Melanoma, News

During this year’s European Society for Medical Oncology (ESMO) 2014 Congress, drug developer Provectus Biopharmaceuticals, Inc., will present a study entitled, “Subgroup efficacy in patients receiving intralesional rose bengal to all existing ... Read more

September 24, 2014September 24, 2014

Telomeres Length May Influence Risk of Developing Melanoma

Melanoma, News

People who have longer telomeres, a compound structure at the end of a chromosome, have higher risk of suffering from melanoma, according to the study “The effect on melanoma risk of ... Read more

September 23, 2014September 23, 2014

PD-L1 in Melanoma Identified As Negative Prognostic Marker

Melanoma, News

In a new study entitled “PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics”, published in the Annals of Oncology journal, a ... Read more

September 22, 2014September 22, 2014

Decision Resources Group Survey Shows that Half of Oncologists Prescribe Tafinlar and Mekinist to Treat Melanoma

Melanoma, News

The consulting company Decision Resources Group, which analyzes critical issues within the healthcare industry, recently concluded that more than half of the surveyed U.S. oncologists prescribe GlaxoSmithKline‘s BRAF inhibitor Tafinlar for BRAF-mutation-positive unresectable or ... Read more

September 22, 2014September 22, 2014

Melanoma Risk Associated with Telomere Length, According to Study

Melanoma, News

Researchers from the University of Leeds, have published a new study entitled “The effect on melanoma risk of genes previously associated with telomere length,” published in the Journal of the National ... Read more

September 18, 2014September 18, 2014

Study Shows Experimental Drug PV-10 Results In Complete Response In 50% Of Melanoma Patients

News

Two studies entitled “Efficacy of intralesional rose bengal in patients receiving injection in all existing melanoma in phase II study PV-10-MM-02” and “Assessment of immune and clinical efficacy after intralesional ... Read more

September 17, 2014September 17, 2014

Breakthrough Advanced Melanoma Treatment Approved by Health Canada

News

Immunotherapy is fast becoming the treatment of choice for many types of cancer as it offers a more natural method to target cancer cells. Canadian melanoma patients received great news ... Read more

September 16, 2014September 16, 2014

Study Shows Possible Link between Viagra and Risk for Melanoma

Melanoma, News

A study entitled “Sildenafil Use and Increased Risk of Incident Melanoma in US Men, A Prospective Cohort Study” and published in the JAMA Internal Medicine journal has shown that there ... Read more

September 15, 2014September 15, 2014

MD Anderson Co-hosts Night Fun Run for Melanoma

Melanoma, News

Melanoma, the most serious type of skin cancer, is expected to be diagnosed in over 76,000 new cases of skin cancer this year alone. In order to raise funds for much needed ... Read more

September 12, 2014September 12, 2014

Study Finds Link Between Genetic Mutation and Melanoma Progression

Melanoma, News

In a study entitled, “BRAFV600E melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity” published in the British Journal of Cancer, scientists from Dartmouth-Hitchcock Norris Cotton Cancer Center in ... Read more

September 11, 2014September 11, 2014

Myriad myPath Melanoma Reduces Indeterminate Diagnosis and May Correct Treatment Recommendations

Melanoma, News

Molecular diagnostic company Myriad Genetics recently presented the results of its pivotal clinical utility study of the Myriad myPath Melanoma test, a new diagnostic tool for determining if a tissue is a malignant melanoma or ... Read more

September 10, 2014September 10, 2014

Melanoma Diagnosis Part of New, Advanced Broad-Spectrum Cancer Detection and Monitoring Platform

Melanoma, News

Aethlon Medical, Inc. and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), have announced that ESI researchers developed and validated a lectin-based diagnostic platform that can isolate exosome-based biomarkers common to several ... Read more

September 9, 2014September 9, 2014

JAMA Dermatology Advocates Changes in Healthcare Melanoma Screening

Melanoma, News

The monthly peer-reviewed medical journal published by the American Medical Association recently advocated changes to the way the nation’s melanoma screens are performed within the healthcare system, considering that there is $2.85 billion in overall lost productivity to the entire economy, in ... Read more

September 8, 2014September 8, 2014

Melanoma Risk Higher for Flight Crews, According to Study

Melanoma, News

A new study entitled “The Risk of Melanoma in Airline Pilots and Cabin Crew” published in the JAMA Dermatology journal has found that pilots and cabin crew members are 2.22 ... Read more

September 4, 2014September 5, 2014

Breakthrough Melanoma Treatment Approved by FDA

Melanoma, News, Skin Cancer

It is estimated that roughly 5% of all newly diagnosed cancers in America are melanomas — a tumor of melanin-forming cells, and ranked as the most serious type of skin ... Read more

September 4, 2014September 4, 2014

New Handheld Device Allows Deeper Melanoma Screening

Melanoma, News

Researchers from Washington University in St. Louis have constructed a hand-held photoacoustic microscopy device that uses lasers and sound waves to measure how deep a melanoma tumor extends into the ... Read more

September 3, 2014September 3, 2014

Amgen Submits Marketing Authorization Application For New Melanoma Immunotherapy

Melanoma, News

Amgen, a biotechnology company developing innovative human therapeutics, has announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval for talimogene laherparepvec as a treatment ... Read more

September 2, 2014

New Melanoma Test Improves Reliability of Melanoma Diagnosis

News

Myriad Genetics, Inc, a leading molecular diagnostic company, has presented results from its pivotal clinical validation study of the Myriad myPath™ Melanoma test at the 2014 American Society of Clinical ... Read more